Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 69101-69150 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05151588
Induction Chemotherapy and Tazemetostat for Locally Advanced SMARCB1-deficient Sinonasal Carcinoma
PHASE2Not yet recruiting
30 participants
Started: Sep 1, 2023 · Completed: Aug 31, 2027
1 condition1 sponsor0 locations
NCT05970484
Supporting Women in the UK Armed Forces Who Consume Alcohol at an Increased Risk: Refining the DrinksRation Platform
NARecruiting
148 participants
Started: Sep 1, 2023 · Completed: Aug 31, 2024
3 conditions5 sponsors1 location
NCT06457906
SRS/SRT/Hypo-RT Versus HA-WBRT for No More Than 10 Brain Metastases in SCLC
PHASE3Recruiting
340 participants
Started: Sep 1, 2023 · Completed: Feb 28, 2028
6 conditions1 sponsor1 location
NCT05166629
Eatable Alphabet as a Nutrition Education Tool
NAEnrolling by invitation
160 participants
Started: Sep 1, 2023 · Completed: Dec 31, 2026
3 conditions1 sponsor1 location
NCT05949229
The Effect of Preoperative Duloxetine on the Occurance of Postoperative Delirium in Patients Undergoing Cancer Surgery.
PHASE1/PHASE2Not yet recruiting
42 participants
Started: Aug 31, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06003309
Frequency and E-field Enhancement of ITBS for Depression (FREED)
NARecruiting
75 participants
Started: Aug 31, 2023 · Completed: Apr 1, 2025
1 condition2 sponsors2 locations
NCT06009029
SBRT Combined With Zimberelimab (GLS-010) in Locally Advanced Pancreatic Cancer (SPARK-1 Study)
PHASE2Not yet recruiting
96 participants
Started: Aug 31, 2023 · Completed: Jul 31, 2027
1 condition1 sponsor0 locations
NCT05883748
Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Efficacy of DISC-1459 (Bitopertin) in Participants with EPP
PHASE2/PHASE3Enrolling by invitation
200 participants
Started: Aug 31, 2023 · Completed: Jun 30, 2028
1 condition1 sponsor11 locations
NCT05708508
Effectiveness of an Immune-guided Cytomegalovirus Infection Preventive Strategy Compared to a Universal Prophylactic Strategy in Renal Transplant Patients
PHASE3Not yet recruiting
144 participants
Started: Aug 31, 2023 · Completed: Jun 1, 2027
1 condition1 sponsor0 locations
NCT05773352
Perform® Humeral System - Fracture Study (PFX)
N/AActive, not recruiting
125 participants
Started: Aug 31, 2023 · Completed: Sep 1, 2033
4 conditions1 sponsor9 locations
NCT06059001
Study to Evaluate the Safety, PK, and Efficacy of the Myc Inhibitor OMO-103 Administered Iv in Patients with PDAC
PHASE1Recruiting
30 participants
Started: Aug 31, 2023 · Completed: Mar 31, 2026
1 condition1 sponsor6 locations
NCT06009588
Comparison of Self- and Balloon-expandable Valves in Patients With Ascending Aortic Dilation Undergoing Transcatheter Aortic Valve Replacement: The AAD-CHOICE
NARecruiting
100 participants
Started: Aug 31, 2023 · Completed: Aug 30, 2026
2 conditions1 sponsor1 location
NCT05701215
Venetoclax After TKI to Target Persisting Stem Cells in CML
PHASE2Active, not recruiting
10 participants
Started: Aug 31, 2023 · Completed: Jan 31, 2026
1 condition3 sponsors2 locations
NCT05994365
Study of Anlotinib Hydrochloride Capsules in the Treatment of Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma
N/ARecruiting
380 participants
Started: Aug 31, 2023 · Completed: Dec 31, 2028
1 condition1 sponsor3 locations
NCT06245759
The Prognostic Impact of Tumor Location in Non-Muscle-Invasive Bladder Cancer Patients
N/ARecruiting
120,000 participants
Started: Aug 31, 2023 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT06051409
A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ALL.
PHASE3Recruiting
350 participants
Started: Aug 31, 2023 · Completed: Oct 31, 2028
1 condition2 sponsors14 locations
NCT06021470
The StrokeCog Study: Cognitive Rehabilitation Intervention in Stroke
NANot yet recruiting
64 participants
Started: Aug 31, 2023 · Completed: Oct 31, 2025
3 conditions1 sponsor0 locations
NCT05924269
Role of Neuronal Guidance Proteins as Diagnostic Markers for Acute Kidney Injury (AKI)
N/ANot yet recruiting
600 participants
Started: Aug 31, 2023 · Completed: Jul 31, 2026
1 condition1 sponsor0 locations
NCT05992974
To Identify Urinary Biomarkers Associated With Gestational Diabetes Mellitus [GDM]
N/ARecruiting
1,000 participants
Started: Aug 31, 2023 · Completed: Dec 31, 2025
1 condition3 sponsors2 locations
NCT06016647
Multi-axis Assessment of Injured Workers
N/ARecruiting
350 participants
Started: Aug 31, 2023 · Completed: Aug 30, 2025
7 conditions2 sponsors1 location
NCT06046066
A Phase 1 Study of NM6603 in Advanced Solid Tumors
PHASE1Recruiting
36 participants
Started: Aug 31, 2023 · Completed: Feb 28, 2026
1 condition1 sponsor4 locations
NCT05788081
Treatment Of Newly-diagnosed Follicular Lymphoma With CELMoD Golcadomide, Rituximab +/- Nivolumab.
PHASE2Active, not recruiting
40 participants
Started: Aug 31, 2023 · Completed: Jun 1, 2027
3 conditions7 sponsors5 locations
NCT05684692
Screening Trial for Pain Relief in Schwannomatosis (STARFISH)
PHASE2Recruiting
40 participants
Started: Aug 31, 2023 · Completed: Nov 30, 2027
3 conditions3 sponsors1 location
NCT06534489
Surgical Strategy of NSCLC Patients After Neo-adjuvant or Induction Treatment
N/ARecruiting
50 participants
Started: Aug 31, 2023 · Completed: Aug 31, 2029
2 conditions4 sponsors1 location
NCT06011980
Life-2023-02 Esophagogastric Variceal Bleeding
NARecruiting
33 participants
Started: Aug 31, 2023 · Completed: Aug 10, 2026
1 condition1 sponsor1 location
NCT05750329
Liver Transplantation With Two-stage Liver Resection in Unresectable Liver Cancer , Metastases or Emd-stage Liver Disease (LTLR-LC)
NANot yet recruiting
30 participants
Started: Aug 31, 2023 · Completed: Dec 31, 2026
3 conditions3 sponsors0 locations
NCT05908695
An Efficacy and Safety Study of Sodium Oligomannate (GV-971) for the Treatment of Alzheimer's Disease
PHASE4Recruiting
1,312 participants
Started: Aug 31, 2023 · Completed: Dec 31, 2029
1 condition1 sponsor50 locations
NCT06036810
Spanish Decision Tool for Ovarian Cancer Maintenance Therapy
NARecruiting
70 participants
Started: Aug 31, 2023 · Completed: Oct 31, 2027
1 condition2 sponsors1 location
NCT06020833
A Single-arm Trial of Roxadustat Combined With Retinoic Acid in the Treatment of Refractory Low-risk MDS
PHASE1/PHASE2Not yet recruiting
25 participants
Started: Aug 31, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor0 locations
NCT06183554
CXCR4 Targeted PET Imaging in the Diagnosis and Identification of Primary Aldosteronism
N/ARecruiting
60 participants
Started: Aug 31, 2023 · Completed: Aug 31, 2025
1 condition1 sponsor1 location
NCT05914389
Induction Chemotherapy Combined With Neoadjuvant Immunotherapy for MSS Colon Cancer
PHASE2Recruiting
100 participants
Started: Aug 31, 2023 · Completed: Aug 31, 2030
1 condition1 sponsor1 location
NCT05983172
Multi-omics Approach of Risk Stratification for Patients With de Novo Acute Myeloid Leukemia
N/AEnrolling by invitation
1,500 participants
Started: Aug 31, 2023 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT05974033
IntraCranial Angiography-derived Fraction Flow-guided Percutaneous Transluminal Angioplasty and Stenting Versus Medical Therapy (ICAS-MT)
NANot yet recruiting
536 participants
Started: Aug 31, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor0 locations
NCT05951023
Endotype-Targeted Therapy to Rescue OSA Patients Struggling with CPAP Adherence (TOP-CPAP)
PHASE2Recruiting
50 participants
Started: Aug 31, 2023 · Completed: Apr 30, 2025
1 condition2 sponsors1 location
NCT05361941
Multicenter Trial of Antibiotic Eluting Graft for Promoting New Bone Growth In/near Infected Bone Cavities
NARecruiting
204 participants
Started: Aug 31, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor12 locations
NCT06042764
SA55 Injection Phase II Study in the Treatment of Mild/Moderate COVID-19 Patients
PHASE2Recruiting
150 participants
Started: Aug 31, 2023 · Completed: Aug 30, 2024
1 condition1 sponsor1 location
NCT05852743
Comparative Study Between Shear and Strain Elastography in Monitoring the Response to NAC in Breast Cancer Patients
N/ANot yet recruiting
65 participants
Started: Aug 31, 2023 · Completed: Apr 30, 2026
1 condition1 sponsor0 locations
NCT05870150
Challenge Non-Typhoidal Salmonella (CHANTS) Study
NAActive, not recruiting
80 participants
Started: Aug 31, 2023 · Completed: Feb 28, 2026
8 conditions5 sponsors1 location
NCT06135766
Evaluating the Effectiveness of a School-based Intervention to Improve the Wellbeing of Children Aged 10 to 13 Years.
NARecruiting
300 participants
Started: Aug 31, 2023 · Completed: Jun 30, 2024
2 conditions1 sponsor1 location
NCT05987826
Study of Furmonertinib as Neoadjuvant Therapy for Resectable Stage Ⅱ-ⅢB EGFR Sensitive Mutant NSCLC
PHASE2Not yet recruiting
40 participants
Started: Aug 31, 2023 · Completed: Dec 31, 2025
1 condition5 sponsors0 locations
NCT06320210
Chicago Asthma School-Directed Child-Centered Assessment and Dissemination of Evidence
NARecruiting
400 participants
Started: Aug 31, 2023 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT05883254
Pumilio1 (PUM1) Expression, Sickle Cell Anemia, β-thalassemia Intermedia
N/ANot yet recruiting
80 participants
Started: Aug 31, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor0 locations
NCT06172374
A Study Providing Genetic Testing to Find Those Who May Have Primary Ciliary Dyskinesia for Potential Clinical Trials
N/AActive, not recruiting
150 participants
Started: Aug 31, 2023 · Completed: Dec 31, 2025
1 condition3 sponsors1 location
NCT06015191
Remote Cardiac Rehab for Adolescents With Congenital Heart Disease
NARecruiting
74 participants
Started: Aug 31, 2023 · Completed: Dec 31, 2027
1 condition5 sponsors1 location
NCT05963087
Cetuximab in Combination With Dabrafenib and Tislelizumab in BRAF Mutated Treatment of Advanced Colorectal Cancer
NANot yet recruiting
22 participants
Started: Aug 31, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05971589
A Clinical Study on LM103 Injection for the Treatment of Advanced Solid Tumors
EARLY_PHASE1Not yet recruiting
5 participants
Started: Aug 31, 2023 · Completed: Aug 31, 2026
1 condition1 sponsor0 locations
NCT06138340
The Effects of Anesthetics on Brain Network Connectivity in Patients With Supratentorial Glioma
N/ARecruiting
120 participants
Started: Aug 31, 2023 · Completed: Dec 31, 2025
4 conditions1 sponsor1 location
NCT06016842
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis
PHASE3Recruiting
276 participants
Started: Aug 31, 2023 · Completed: May 31, 2029
1 condition1 sponsor158 locations
NCT06028308
The Effect of Adding Auditory Information on Head Movements in People With Traumatic Neck Pain
NANot yet recruiting
44 participants
Started: Aug 31, 2023 · Completed: Sep 30, 2026
2 conditions1 sponsor2 locations
NCT05945758
Esthetic and Clinical Assessment of Injectable Resin Composite Technique
NANot yet recruiting
20 participants
Started: Aug 31, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor0 locations